129 related articles for article (PubMed ID: 12036219)
1. Knowledge, attitudes and experience associated with testing for prostate cancer: a comparison between male doctors and men in the community.
Livingston P; Cohen P; Frydenberg M; Borland R; Reading D; Clarke V; Hill D
Intern Med J; 2002; 32(5-6):215-23. PubMed ID: 12036219
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
3. PSA testing and digital rectal examination in New Zealand.
Sneyd MJ; Cox B; Paul C; Skegg DC
Aust N Z J Public Health; 2003 Oct; 27(5):502-6. PubMed ID: 14651394
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
5. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination.
Leewansangtong S; Tantiwong A; Ratanarapee S; Nualyong C; Soontrapa S
J Med Assoc Thai; 2000 Dec; 83(12):1519-24. PubMed ID: 11253893
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience.
Mirone V; Imbimbo C; Arcaniolo D; Franco M; La Rocca R; Venturino L; Spirito L; Creta M; Verze P
World J Urol; 2017 Dec; 35(12):1857-1862. PubMed ID: 28780740
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
8. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
9. Why do men refuse or attend population-based screening for prostate cancer?
Nijs HG; Essink-Bot ML; DeKoning HJ; Kirkels WJ; Schröder FH
J Public Health Med; 2000 Sep; 22(3):312-6. PubMed ID: 11077903
[TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
11. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
Hattangadi JA; Chen MH; D'Amico AV
BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.
Morlando M; Pelullo CP; Di Giuseppe G
PLoS One; 2017; 12(10):e0186332. PubMed ID: 29023514
[TBL] [Abstract][Full Text] [Related]
13. Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
Wilt TJ; Paul J; Murdoch M; Nelson D; Nugent S; Rubins HB
Eff Clin Pract; 2001; 4(3):112-20. PubMed ID: 11434074
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer testing: behaviour, motivation and attitudes among Western Australian men.
Slevin TJ; Donnelly N; Clarkson JP; English DR; Ward JE
Med J Aust; 1999 Aug; 171(4):185-8. PubMed ID: 10494233
[TBL] [Abstract][Full Text] [Related]
15. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
16. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.
Mercer SL; Goel V; Levy IG; Ashbury FD; Iverson DC; Iscoe NA
Can J Public Health; 1997; 88(5):327-32. PubMed ID: 9401168
[TBL] [Abstract][Full Text] [Related]
18. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
19. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
[TBL] [Abstract][Full Text] [Related]
20. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
